|
1
|
Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
|
Cancer Res
|
2005
|
1.60
|
|
2
|
Bioavailability issues in studying the health effects of plant polyphenolic compounds.
|
Mol Nutr Food Res
|
2008
|
1.59
|
|
3
|
Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase.
|
Carcinogenesis
|
2004
|
1.51
|
|
4
|
Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice.
|
J Nutr
|
2003
|
1.40
|
|
5
|
Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice.
|
J Agric Food Chem
|
2004
|
1.40
|
|
6
|
Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions.
|
J Agric Food Chem
|
2005
|
1.36
|
|
7
|
Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma.
|
Clin Cancer Res
|
2009
|
1.33
|
|
8
|
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.
|
J Clin Oncol
|
2009
|
1.33
|
|
9
|
A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice.
|
Cancer Prev Res (Phila)
|
2009
|
1.27
|
|
10
|
Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro.
|
Carcinogenesis
|
2010
|
1.24
|
|
11
|
Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues.
|
Drug Metab Dispos
|
2005
|
1.24
|
|
12
|
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.
|
Cancer
|
2012
|
1.22
|
|
13
|
Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China.
|
Carcinogenesis
|
2002
|
1.22
|
|
14
|
Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats.
|
Chem Res Toxicol
|
2002
|
1.18
|
|
15
|
A gamma-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth.
|
Carcinogenesis
|
2010
|
1.16
|
|
16
|
Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumor growth in rats.
|
Nutr Cancer
|
2007
|
1.16
|
|
17
|
Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.
|
Drug Metab Dispos
|
2006
|
1.14
|
|
18
|
Stimulatory effect of oral administration of tea, coffee or caffeine on UVB-induced apoptosis in the epidermis of SKH-1 mice.
|
Toxicol Appl Pharmacol
|
2006
|
1.12
|
|
19
|
Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice.
|
J Agric Food Chem
|
2011
|
1.08
|
|
20
|
Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice.
|
Chem Res Toxicol
|
2005
|
1.08
|
|
21
|
δ-tocopherol is more active than α - or γ -tocopherol in inhibiting lung tumorigenesis in vivo.
|
Cancer Prev Res (Phila)
|
2011
|
1.07
|
|
22
|
Inhibition of lung cancer growth in mice by dietary mixed tocopherols.
|
Mol Nutr Food Res
|
2009
|
1.03
|
|
23
|
Analysis of multiple metabolites of tocopherols and tocotrienols in mice and humans.
|
J Agric Food Chem
|
2010
|
1.03
|
|
24
|
Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers.
|
Int J Mol Epidemiol Genet
|
2010
|
1.01
|
|
25
|
δ- and γ-tocopherols, but not α-tocopherol, inhibit colon carcinogenesis in azoxymethane-treated F344 rats.
|
Cancer Prev Res (Phila)
|
2012
|
0.98
|
|
26
|
Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice.
|
Cancers (Basel)
|
2011
|
0.97
|
|
27
|
Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins.
|
Nutr Cancer
|
2007
|
0.97
|
|
28
|
Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia.
|
Mol Carcinog
|
2012
|
0.93
|
|
29
|
Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.
|
Mol Cancer Ther
|
2007
|
0.87
|
|
30
|
Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise.
|
Nutr Cancer
|
2012
|
0.87
|
|
31
|
Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition.
|
Rapid Commun Mass Spectrom
|
2008
|
0.86
|
|
32
|
Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate.
|
Carcinogenesis
|
2008
|
0.85
|
|
33
|
Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer.
|
Cancer Prev Res (Phila)
|
2012
|
0.85
|
|
34
|
The antioxidant and anti-inflammatory activities of tocopherols are independent of Nrf2 in mice.
|
Free Radic Biol Med
|
2011
|
0.84
|
|
35
|
Inhibitory effects of different forms of tocopherols, tocopherol phosphates, and tocopherol quinones on growth of colon cancer cells.
|
J Agric Food Chem
|
2013
|
0.81
|
|
36
|
Tocopherol supplementation reduces NO production and pulmonary inflammatory response to bleomycin.
|
Nitric Oxide
|
2013
|
0.80
|
|
37
|
Metabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cells.
|
Genes Nutr
|
2011
|
0.77
|